Pharmaceutical Sales & Prescription Data
Aggregated prescription and pharmaceutical sales data by therapeutic area, geography, and time period for market analysis.
Overview
The Pharmaceutical Sales & Prescription Data from MedData Corp provides aggregated pharmaceutical sales and prescription volume data across the United States. Data is segmented by therapeutic area, drug name (brand and generic), geographic region (state, metro area, ZIP code), distribution channel (retail pharmacy, mail order, hospital), and time period (weekly, monthly, quarterly).
Metrics include total prescriptions dispensed, new prescriptions, refill rate, total revenue, market share, and growth rates. All data is aggregated from pharmacy claims and distributor sell-through data with no patient-level information exposed.
Used by pharmaceutical companies for commercial planning, biotech firms sizing market opportunities, healthcare consultancies benchmarking drug performance, investors analyzing pharmaceutical revenue trends, and payers evaluating drug utilization patterns.
Metrics include total prescriptions dispensed, new prescriptions, refill rate, total revenue, market share, and growth rates. All data is aggregated from pharmacy claims and distributor sell-through data with no patient-level information exposed.
Used by pharmaceutical companies for commercial planning, biotech firms sizing market opportunities, healthcare consultancies benchmarking drug performance, investors analyzing pharmaceutical revenue trends, and payers evaluating drug utilization patterns.
Data Schema
| Field | Type | Example |
|---|---|---|
| drug_name | String | Lipitor |
| generic_name | String | Atorvastatin |
| therapeutic_area | String | Cardiovascular |
| total_rxs | Integer | 2847190 |
| new_rxs | Integer | 482917 |
| revenue_usd | Float | 125000000.00 |
| market_share | Float | 0.234 |
| period | String | 2026-Q1 |
Data Preview
| drug_name | generic_name | therapeutic_area | total_rxs | new_rxs | revenue_usd | market_share | period |
|---|---|---|---|---|---|---|---|
| Lipitor | Atorvastatin | Cardiovascular | 2847190 | 482917 | 125000000.00 | 0.234 | 2026-Q1 |
| Lipitor | Atorvastatin | Cardiovascular | 3701347 | 627792 | 156250000.00 | 0.29 | 2060-Q35 |
| Lipit4 | Atorvastat4 | Cardiovascul4 | 1993033 | 338042 | 85000000.00 | 0.16 | 2026-4 |
| Lipitor | Atorvastatin | Cardiovascular | 5979099 | 1014126 | 233750000.00 | 0.44 | 2029-Q4 |
Preview limited. Sign up to access full sample data.
Geographic Coverage
United States
Use Cases
Pharmaceutical market analysis
Drug launch planning
Market share tracking
Revenue forecasting
Payer analytics
Key Attributes
Product NamePriceZIP CodeTransaction Date